Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.Financial_Report.xls
10-Q - FORM 10-Q - ProUroCare Medical Inc.v325918_10q.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R32.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R30.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R31.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R29.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - ProUroCare Medical Inc.R27.htm
EX-31.2 - EXHIBIT 31.2 - ProUroCare Medical Inc.v325918_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - ProUroCare Medical Inc.v325918_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - ProUroCare Medical Inc.v325918_ex31-1.htm
EX-10.4 - EXHIBIT 10.4 - ProUroCare Medical Inc.v325918_ex10-4.htm
v2.4.0.6
Notes Payable - Bank. (Details Textual) (USD $)
3 Months Ended 9 Months Ended 157 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2012
Crown Bank [Member]
Sep. 30, 2012
Crown Bank [Member]
Sep. 30, 2012
Central Bank [Member]
Jul. 17, 2012
Central Bank [Member]
Jan. 17, 2012
Central Bank [Member]
Sep. 30, 2012
Central Bank [Member]
Sep. 30, 2012
Central Bank [Member]
Scenario, Forecast [Member]
Sep. 30, 2012
Line Of Credit [Member]
Central Bank [Member]
Sep. 30, 2012
Line Of Credit [Member]
Central Bank [Member]
Sep. 30, 2012
Line Of Credit [Member]
Central Bank [Member]
Scenario, Forecast [Member]
Sep. 30, 2012
Convertible Subordinated Debt [Member]
Crown Bank [Member]
Guarantor [Member]
Mar. 30, 2012
Convertible Subordinated Debt [Member]
Crown Bank [Member]
Guarantor [Member]
Proceeds from long-term convertible notes payable - related parties     $ 200,000 $ 150,000 $ 1,913,500                     $ 200,000  
Debt Instrument, Interest Rate, Effective Percentage                                 10.00%
Stock Issued During Period Shares To Guarantors (in shares)             150,000   9,088                
Stock Issued During Period Shares To Guarantors (in shares)             281,610     6,666 13,633       8,064    
Amount Agreed To Be Paid By Guarantors                           8,145      
Stock Issued During Period Value For Guarantors             453,190       12,268            
Total Number Of Shares Issued In Settlement Of Debt (in shares)             431,610                    
Gains Losses On Extinguishment Of Debt Related Party 191,490 81,520 456,534 282,166 1,525,797 191,490 456,534                    
Notes Payable to Bank                   100,025              
Debt Instrument, Maturity Date                     Jan. 17, 2013     May 12, 2013   Mar. 31, 2014  
Shares Issued for Debt Issuance Period Shares (in shares)                       1,515     1,344    
Debt extinguishment expense 25,846 12,334 101,786 36,185 1,526,677     3,862     12,083   3,984 6,153      
Line of Credit Facility, Maximum Borrowing Capacity                         100,000 100,000      
Line of Credit Facility, Interest Rate Description               The renewed loan matures on January 17, 2013, and bears interest at the prime rate plus 1%, with a minimum annual rate of 5.0% (currently 5%).           Principal amounts borrowed against the line of credit will bear interest at the prime rate plus 1.0%, with a minimum rate of 5.0% (currently 5%).      
Interest expense $ 40,385 $ 30,566 $ 105,338 $ 84,293 $ 5,642,991               $ 0 $ 3,956